Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1540

1.

Adherences to oral nutritional supplementation among hospital outpatients: An online cross-sectional survey in Japan.

Hashizume N, Tanaka Y, Fukahori S, Ishii S, Saikusa N, Koga Y, Higashidate N, Masui D, Sakamoto S, Yagi M.

PLoS One. 2019 Sep 26;14(9):e0222972. doi: 10.1371/journal.pone.0222972. eCollection 2019.

2.

Probiotic L. gasseri strain (LG21) for the upper gastrointestinal tract acting through improvement of indigenous microbiota.

Koga Y, Ohtsu T, Kimura K, Asami Y.

BMJ Open Gastroenterol. 2019 Aug 12;6(1):e000314. doi: 10.1136/bmjgast-2019-000314. eCollection 2019. Review.

3.

The Gut Microbiome Derived From Anorexia Nervosa Patients Impairs Weight Gain and Behavioral Performance in Female Mice.

Hata T, Miyata N, Takakura S, Yoshihara K, Asano Y, Kimura-Todani T, Yamashita M, Zhang XT, Watanabe N, Mikami K, Koga Y, Sudo N.

Endocrinology. 2019 Oct 1;160(10):2441-2452. doi: 10.1210/en.2019-00408.

PMID:
31504398
4.

Fluorine-Substituted Arylphosphine for an NHC-Ni(I) System, Air-Stable in a Solid State but Catalytically Active in Solution.

Matsubara K, Fujii T, Hosokawa R, Inatomi T, Yamada Y, Koga Y.

Molecules. 2019 Sep 4;24(18). pii: E3222. doi: 10.3390/molecules24183222.

5.

GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis.

Nohara S, Ishii A, Yamamoto F, Yanagiha K, Moriyama T, Tozaka N, Miyake Z, Yatsuga S, Koga Y, Hosaka T, Terada M, Yamaguchi T, Aizawa S, Mamada N, Tsuji H, Tomidokoro Y, Nakamagoe K, Ishii K, Watanabe M, Tamaoka A.

J Neurol Sci. 2019 Aug 22;405:116429. doi: 10.1016/j.jns.2019.116429. [Epub ahead of print]

PMID:
31476622
6.

Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10.

Kadoya T, Sakakibara A, Kitayama K, Yamada Y, Higuchi S, Kawakita R, Kawasaki Y, Fujino M, Murakami Y, Shimura M, Murayama K, Ohtake A, Okazaki Y, Koga Y, Yorifuji T.

J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1181-1185. doi: 10.1515/jpem-2019-0205.

PMID:
31473688
7.

Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway.

Sato M, Aoki-Saito H, Fukuda H, Ikeda H, Koga Y, Yatomi M, Tsurumaki H, Maeno T, Saito T, Nakakura T, Mori T, Yanagawa M, Abe M, Sako Y, Dobashi K, Ishizuka T, Yamada M, Shuto S, Hisada T.

FASEB J. 2019 Aug 30:fj201900283R. doi: 10.1096/fj.201900283R. [Epub ahead of print]

PMID:
31469599
8.

Oxytocin and Stress: Neural Mechanisms, Stress-Related Disorders, and Therapeutic Approaches.

Matsushita H, Latt HM, Koga Y, Nishiki T, Matsui H.

Neuroscience. 2019 Aug 7;417:1-10. doi: 10.1016/j.neuroscience.2019.07.046. [Epub ahead of print]

PMID:
31400490
9.

U3-1402, a novel HER3-targeting antibody-drug conjugate, for the treatment of Colorectal Cancer.

Koganemaru S, Kuboki Y, Koga Y, Kojima T, Yamauchi M, Maeda N, Kagari T, Hirotani K, Yasunaga M, Matsumura Y, Doi T.

Mol Cancer Ther. 2019 Aug 8. pii: molcanther.0452.2019. doi: 10.1158/1535-7163.MCT-19-0452. [Epub ahead of print]

PMID:
31395690
10.

Clinicopathological review of solitary fibrous tumors: dedifferentiation is a major cause of patient death.

Yamada Y, Kohashi K, Kinoshita I, Yamamoto H, Iwasaki T, Yoshimoto M, Ishihara S, Toda Y, Itou Y, Koga Y, Hashisako M, Nozaki Y, Kiyozawa D, Kitahara D, Inoue T, Mukai M, Honda Y, Toyokawa G, Tsuchihashi K, Matsushita Y, Fushimi F, Taguchi K, Tamiya S, Oshiro Y, Furue M, Nakashima Y, Suzuki S, Iwaki T, Oda Y.

Virchows Arch. 2019 Aug 7. doi: 10.1007/s00428-019-02622-9. [Epub ahead of print]

PMID:
31392468
11.

Severe Fever with Thrombocytopenia Syndrome Complicated with Pseudomembranous Aspergillus Tracheobronchitis in a Patient without Apparent Risk Factors for Invasive Aspergillosis: A Case Report.

Sakaguchi K, Koga Y, Yagi T, Nakahara T, Todani M, Fujita M, Tsuruta R.

Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3257-19. [Epub ahead of print]

12.

Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft models.

Tsumura R, Manabe S, Takashima H, Koga Y, Yasunaga M, Matsumura Y.

Cancer Sci. 2019 Oct;110(10):3296-3305. doi: 10.1111/cas.14146. Epub 2019 Aug 29.

13.

Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.

Kasahara N, Kaira K, Yamaguchi K, Masubuchi H, Tsurumaki H, Hara K, Koga Y, Sakurai R, Higuchi T, Handa T, Oyama T, Yokobori T, Shimizu K, Asao T, Hisada T.

Lung Cancer. 2019 Aug;134:180-186. doi: 10.1016/j.lungcan.2019.06.009. Epub 2019 Jun 11.

PMID:
31319979
14.

Pipeliner: A Nextflow-Based Framework for the Definition of Sequencing Data Processing Pipelines.

Federico A, Karagiannis T, Karri K, Kishore D, Koga Y, Campbell JD, Monti S.

Front Genet. 2019 Jun 28;10:614. doi: 10.3389/fgene.2019.00614. eCollection 2019.

15.

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?

Yamashita K, Iwatsuki M, Harada K, Koga Y, Kiyozumi Y, Eto K, Hiyoshi Y, Ishimoto T, Iwagami S, Baba Y, Miyamoto Y, Yoshida N, Komohara Y, Ajani JA, Baba H.

Br J Cancer. 2019 Jul;121(3):278-280. doi: 10.1038/s41416-019-0515-5. Epub 2019 Jul 9.

PMID:
31285589
16.

Clinicopathological features and phenotypic classification of de novo-type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas.

Koga Y, Hirahashi M, Ohishi Y, Oda Y.

Pathol Int. 2019 Jun;69(6):331-340. doi: 10.1111/pin.12803. Epub 2019 Jul 7.

PMID:
31282116
17.

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis.

Tsurumaki H, Matsuyama T, Ezawa K, Koga Y, Yatomi M, Aoki-Saito H, Chikamatsu K, Hisada T.

Medicina (Kaunas). 2019 Jul 3;55(7). pii: E336. doi: 10.3390/medicina55070336.

18.

[A Survey on the Status of Countermeasures against Anticancer Drug Exposure for Families-Focus on Pediatric Cancer Hospitals].

Ohta M, Noda Y, Miyazono M, Koga Y, Kifune M, Hamada M, Taguchi T, Ohga S.

Gan To Kagaku Ryoho. 2019 Apr;46(4):673-677. Japanese.

PMID:
31164505
19.

Clinical significance of evaluating endoscopic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma.

Nagai Y, Yoshida N, Baba Y, Harada K, Imai K, Iwatsuki M, Karashima R, Koga Y, Nomoto D, Okadome K, Ishimoto T, Imamura Y, Watanabe M, Baba H.

Dig Endosc. 2019 May 23. doi: 10.1111/den.13449. [Epub ahead of print]

PMID:
31120560
20.

Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels.

Koga Y, Hachisu Y, Tsurumaki H, Yatomi M, Kaira K, Ohta S, Ono J, Izuhara K, Dobashi K, Hisada T.

Medicina (Kaunas). 2019 May 17;55(5). pii: E161. doi: 10.3390/medicina55050161.

21.

Adverse Effects on the Postoperative Urinary Function After Combined Resection of Inferior Vesical Artery in Laparoscopic Lateral Pelvic Lymph Node Dissection: Retrospective Analysis of Consecutive 95 Series.

Manabe T, Koga Y, Kubo H, Baba K, Nagayoshi K, Nagai S, Ueki T, Nakamura M, Noshiro H.

Surg Laparosc Endosc Percutan Tech. 2019 May 15. doi: 10.1097/SLE.0000000000000681. [Epub ahead of print]

PMID:
31107856
22.

Development and evaluation of a jaw-tracking system for mice: reconstruction of three-dimensional movement trajectories on an arbitrary point on the mandible.

Moriuchi E, Hamanaka R, Koga Y, Fujishita A, Yoshimi T, Yasuda G, Kohara H, Yoshida N.

Biomed Eng Online. 2019 May 16;18(1):59. doi: 10.1186/s12938-019-0672-z.

23.

An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer.

Kaira K, Imai H, Souma R, Sakurai R, Miura Y, Sunaga N, Kasahara N, Tsukagoshi Y, Koga Y, Kitahara S, Kotake M, Minato K, Naruse I, Fukushima Y, Hisada T, Ishizuka T.

Anticancer Res. 2019 May;39(5):2483-2491. doi: 10.21873/anticanres.13368.

PMID:
31092443
24.

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Hachisu Y, Murata K, Takei K, Tsuchiya T, Tsurumaki H, Koga Y, Horie T, Takise A, Hisada T.

Medicina (Kaunas). 2019 May 13;55(5). pii: E132. doi: 10.3390/medicina55050132.

25.

Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors.

Koga Y, Ochiai A.

Cells. 2019 May 6;8(5). pii: E418. doi: 10.3390/cells8050418. Review.

26.

Proximity Gettering Design of Hydrocarbon⁻Molecular⁻Ion⁻Implanted Silicon Wafers Using Dark Current Spectroscopy for CMOS Image Sensors.

Kurita K, Kadono T, Shigematsu S, Hirose R, Okuyama R, Onaka-Masada A, Okuda H, Koga Y.

Sensors (Basel). 2019 May 4;19(9). pii: E2073. doi: 10.3390/s19092073.

27.

A case of combined 21-hydroxylase deficiency and CHARGE syndrome featuring micropenis and cryptorchidism.

Umino S, Kitamura M, Katoh-Fukui Y, Fukami M, Usui T, Yatsuga S, Koga Y.

Mol Genet Genomic Med. 2019 Jun;7(6):e730. doi: 10.1002/mgg3.730. Epub 2019 May 6.

28.

Predictive value of the ratio of 8‑hydroxydeoxyguanosine levels between cancerous and normal tissues in patients with stage II/III colorectal cancer.

Kitagawa H, Kitajima Y, Kai K, Komukai S, Tanaka T, Koga Y, Manabe T, Noshirο H.

Oncol Rep. 2019 May;41(5):3041-3050. doi: 10.3892/or.2019.7086. Epub 2019 Mar 22.

PMID:
30964148
29.

Publisher Correction: Fgf10 is essential for limb and lung formation.

Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, Yagishita N, Matsui D, Koga Y, Itoh N, Kato S.

Nat Genet. 2019 May;51(5):921. doi: 10.1038/s41588-019-0396-9.

PMID:
30948796
30.

Preservation of physiological passage through the remnant stomach prevents postoperative malnutrition after proximal gastrectomy with double tract reconstruction.

Yamashita K, Iwatsuki M, Koga Y, Toihata T, Kiyozumi Y, Kuroda D, Eto K, Hiyoshi Y, Iwagami S, Baba Y, Miyamoto Y, Yoshida N, Baba H.

Surg Today. 2019 Sep;49(9):748-754. doi: 10.1007/s00595-019-01799-5. Epub 2019 Mar 30.

PMID:
30929080
31.

Effect on inclined medial proximal tibial articulation for varus alignment in advanced knee osteoarthritis.

Mochizuki T, Koga Y, Tanifuji O, Sato T, Watanabe S, Koga H, Kobayashi K, Omori G, Endo N.

J Exp Orthop. 2019 Mar 28;6(1):14. doi: 10.1186/s40634-019-0180-x.

32.

Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.

Yamagishi SI, Koga Y, Sotokawauchi A, Hashizume N, Fukahori S, Matsui T, Yagi M.

Curr Pharm Des. 2019;25(3):313-324. doi: 10.2174/1381612825666190319112106.

PMID:
30892156
33.

Roles of Cyclic AMP Response Element Binding Activation in the ERK1/2 and p38 MAPK Signalling Pathway in Central Nervous System, Cardiovascular System, Osteoclast Differentiation and Mucin and Cytokine Production.

Koga Y, Tsurumaki H, Aoki-Saito H, Sato M, Yatomi M, Takehara K, Hisada T.

Int J Mol Sci. 2019 Mar 17;20(6). pii: E1346. doi: 10.3390/ijms20061346. Review.

34.

Inhibitory Effects of Short-Chain Fatty Acids and ω-3 Polyunsaturated Fatty Acids on Profibrotic Factors in Dermal Fibroblasts.

Maeshige N, Torii K, Tabuchi H, Imai M, Koga Y, Uemura M, Aoyama-Ishikawa M, Miyoshi M, Fujino H, Terashi H, Usami M.

Eplasty. 2019 Mar 1;19:e4. eCollection 2019.

35.

The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.

Koga Y, Iwatsuki M, Yamashita K, Kiyozumi Y, Kurashige J, Masuda T, Eto K, Iwagami S, Harada K, Ishimoto T, Baba Y, Yoshida N, Miyanari N, Takamori H, Ajani JA, Baba H.

Gastric Cancer. 2019 Mar 11. doi: 10.1007/s10120-019-00950-y. [Epub ahead of print]

PMID:
30854619
36.

[Prospect of prebiotics for the treatment of gastrointestinal diseases via the activation of butyrate-producing commensal bacteria].

Koga Y, Mine T.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(3):224-234. doi: 10.11405/nisshoshi.116.224. Japanese. No abstract available.

PMID:
30853675
37.

[Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].

Tamefusa K, Fukutake K, Ishida H, Tamura A, Endo M, Hamamoto K, Koga Y, Yamada M, Kanamitsu K, Fujiwara K, Washio K, Shimada A.

Rinsho Ketsueki. 2019;60(2):99-105. doi: 10.11406/rinketsu.60.99. Japanese.

PMID:
30842387
38.

Versatile Synthetic Route to Cycloheximide and Analogues That Potently Inhibit Translation Elongation.

Park Y, Koga Y, Su C, Waterbury AL, Johnny CL, Liau BB.

Angew Chem Int Ed Engl. 2019 Apr 8;58(16):5387-5391. doi: 10.1002/anie.201901386. Epub 2019 Mar 19.

PMID:
30802354
39.

The morphology of the femur in elderly Japanese females: Analysis using 3D-CT.

Maehara T, Kiyono M, Noda T, Sato R, Kadota H, Hori T, Koga Y, Hidaka Y, Joko R, Muraoka S, Ozaki T.

J Orthop Surg (Hong Kong). 2019 Jan-Apr;27(1):2309499018816488. doi: 10.1177/2309499018816488.

PMID:
30798708
40.

Navigation surgery using indocyanine green fluorescent imaging for hepatoblastoma patients.

Souzaki R, Kawakubo N, Matsuura T, Yoshimaru K, Koga Y, Takemoto J, Shibui Y, Kohashi K, Hayashida M, Oda Y, Ohga S, Taguchi T.

Pediatr Surg Int. 2019 May;35(5):551-557. doi: 10.1007/s00383-019-04458-5. Epub 2019 Feb 16.

PMID:
30778701
41.

Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952.

Ikegashira K, Ikenogami T, Yamasaki T, Oka T, Hase Y, Miyagawa N, Inagaki K, Kawahara I, Koga Y, Hashimoto H.

Bioorg Med Chem Lett. 2019 Apr 1;29(7):873-877. doi: 10.1016/j.bmcl.2019.02.006. Epub 2019 Feb 7.

PMID:
30755337
42.

Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.

Koga Y, Povalko N, Inoue E, Nashiki K, Tanaka M.

Mitochondrion. 2019 Sep;48:11-15. doi: 10.1016/j.mito.2019.02.001. Epub 2019 Feb 7.

PMID:
30738201
43.

Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.

Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, Kato K, Atsuta Y, Ishida H.

Bone Marrow Transplant. 2019 Sep;54(9):1489-1498. doi: 10.1038/s41409-019-0461-0. Epub 2019 Feb 4.

PMID:
30718800
44.

The Influence of Sarcopenia on High-Risk Neuroblastoma.

Kawakubo N, Kinoshita Y, Souzaki R, Koga Y, Oba U, Ohga S, Taguchi T.

J Surg Res. 2019 Apr;236:101-105. doi: 10.1016/j.jss.2018.10.048. Epub 2018 Dec 7.

PMID:
30694741
45.

The dual role of viscosity in capillary rise.

Delannoy J, Lafon S, Koga Y, Reyssat É, Quéré D.

Soft Matter. 2019 Apr 7;15(13):2757-2761. doi: 10.1039/c8sm02485e. Epub 2019 Jan 29.

PMID:
30693361
46.

Temple syndrome diagnosed in an adult patient with clinical autism spectrum disorder.

Kimura T, Kagami M, Matsubara K, Yatsuga S, Mukasa R, Yatsuga C, Matsumoto T, Koga Y.

Clin Case Rep. 2018 Nov 8;7(1):15-18. doi: 10.1002/ccr3.1895. eCollection 2019 Jan.

47.

A new hydrophilic polysulfone hemodialysis membrane can prevent platelet-neutrophil interactions and successive neutrophil activation.

Koga Y, Meguro H, Fujieda H, Ueno Y, Miwa K, Kainoh M.

Int J Artif Organs. 2019 Apr;42(4):175-181. doi: 10.1177/0391398818823767. Epub 2019 Jan 14.

48.

Secretion analysis of intracellular "difficult-to-express" immunoglobulin G (IgG) in Chinese hamster ovary (CHO) cells.

Kaneyoshi K, Kuroda K, Uchiyama K, Onitsuka M, Yamano-Adachi N, Koga Y, Omasa T.

Cytotechnology. 2019 Feb;71(1):305-316. doi: 10.1007/s10616-018-0286-5. Epub 2019 Jan 12.

PMID:
30637508
49.

Primary amelanotic malignant melanoma of the esophagus: a case report.

Koga N, Kubo N, Saeki H, Sasaki S, Jogo T, Hirose K, Nakashima Y, Oki E, Koga Y, Oda Y, Oiwa H, Oiwa T, Maehara Y.

Surg Case Rep. 2019 Jan 11;5(1):4. doi: 10.1186/s40792-019-0564-2.

50.

Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey.

Fujita M, Oda Y, Kaneda K, Kawamura Y, Nakahara T, Todani M, Yagi T, Koga Y, Tsuruta R.

Emerg Med Int. 2018 Dec 4;2018:2159147. doi: 10.1155/2018/2159147. eCollection 2018.

Supplemental Content

Support Center